Anbio Biotechnology: rnd_expense
| Value | {"amount": 200000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2be33f50-3051-49e1-8782-592def7da9e7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/rnd-expense/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2be33f50-3051-49e1-8782-592def7da9e7
History
- no predecessors — first report